Company intelligence / Profile preview

OpenCell BioMed

Toronto, Ontario, Canada

Ownership: Private
Development stage: Other

Overview

OpenCell Biomed is a medical device company that specialized in the development and manufacturing of advanced dental implants. The company's core innovation was the TI-FOAM™ technology, a porous titanium surface coating designed to enhance osseointegration and long-term stability of dental implants. Their product line, including the Third Generation (G3) Dental Implant System, was designed to address common industry issues such as peri-implantitis and long clinical treatment times. Founded in 2007 and based in Toronto, Canada, OpenCell Biomed was acquired by Preferred Commerce in 2014.

Therapeutic areas: OtherInfectious Diseases
Modalities: DeviceNanoparticle
Industry: Implantable Medical Devices

Partnerships

National Research Council of Canada

Beyond the preview

Go deeper on OpenCell BioMed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OpenCell BioMed.

Explore the full profile